Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

American Oriental Bioengineering: All Dressed Up, Nowhere to Go

publication date: Mar 22, 2011
American Oriental Bioengineering has announced that the company’s Board of Directors authorized a $20 million share buyback. Sometimes, Board of Directors decide to initiate buybacks after reaching a high-minded, well-researched decision that its own stock is the best investment available anywhere on the globe. More often, buybacks are a small sop thrown to shareholders to lessen the pain from negative news. Unfortunately, this is a case of the latter. We explain why. More details....

Stock Symbol: (NYSE: AOB)     Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming event
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China